GSK extension
-
First floor
GSK extension. Stabilization of Siena and Rosia workers. Union agreement without Filctem CGIL
The discussion table has been open since April, after the summer break and the new decree law…
Leggi » -
News
GSK acquires 36.5% of the Consumer Health joint venture from Novartis
Rome, 28 March – RIF Day – Novartis has reached an agreement with GlaxoSmithKline (Gsk) to sell them its 36.5%…
Leggi » -
News
RSU GSK elections. Filctem in the majority, Femca on the rise
Thursday 1 February, at the end of the three days that Gsk vaccines employees, working at the Siena and Rosia sites,…
Leggi » -
News
Silent revolution in GSK, the new CEO replaces 40 percent of the management
Emma Walmsley, new CEO of GlaxoSmithKline, replaced 50 top managers in a few months, 40% of the highest…
Leggi » -
News
The growth of Italy and the case of the pharmaceutical industry
In Italy, growth is accelerating. Istat data say so in a preliminary estimate of the second quarter of 2017. The Product…
Leggi » -
News
British GSK to cut 320 jobs in the UK. Verona closes: 300 workers at risk in Italy
It is a consequence of the sale of the brands Horlicks 'and 'MaxiNutrition' EUROPA PRESS – 07/19/2017 – el Economista The pharmaceutical house…
Leggi » -
News
Filctem Siena: what future for Gsk?
“Just over a year after GSK announced its intention to invest around 600 million in Sienese sites,…
Leggi » -
News
Emma Walmsley is the new Chief Executive Officer of GSK
Emma Walmsley has been appointed Chief Executive Officer of GlaxoSmithKline plc effective 1 April 2017. Emma has joined GSK…
Leggi » -
News
Emma Walmsley new CEO of GlaxoSmithKline
Surprise at GlaxoSmithKline with the appointment of Emma Walmsley, an internal, as CEO of the pharmaceutical company. The nomination is…
Leggi » -
News
Parma. Gsk, Filctem: risk of strong employment contraction
Sale agreement by GSK (GlaxoSmithKline) of the anesthetics portfolio in Aspen, with the relocation of production. Strong concern, above all…
Leggi »